Dr. Nana Kobaivanova, MD

Dr. Kobaivanova practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Kobaivanova's NPI, 1447208640, was assigned on May 4, 2006. Dr. Kobaivanova holds Ohio license 35081513.

Dr. Kobaivanova's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Kobaivanova's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Kobaivanova is also affiliated with Hillcrest Hospital. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Kobaivanova to 1 more hospital, 2 clinical labs and 1 group practice or clinic, each named with a free account. Dr. Kobaivanova's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kobaivanova practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Kobaivanova's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Kobaivanova is licensed in Ohio.

CMS data shows 326 Medicare services from Dr. Kobaivanova across 4 procedure codes in 2024, for 113 Medicare patients. Medicare paid $10,698 for them. Every service was in an office.

CMS counts 113 Medicare patients who saw Dr. Kobaivanova in 2024. The largest group is 65 to 74, with 52 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 35% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kobaivanova's median patient age at 64, with 63% women.

In 2024, Dr. Kobaivanova wrote 4,790 Medicare Part D claims for 423 patients. 83% of them were for generic drugs. CMS names the drug for 4,216 of them, across 93 drugs with 11 or more claims each, at $392,141 in total drug cost. In 2023, CMS named 2,112 claims across 55 drugs.

Dr. Kobaivanova accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Kobaivanova, published from 2017 to 2021. Dr. Kobaivanova's most frequent co-authors are Andrei C. Brateanu, MD, Thomas J. Barwacz, MD and Shari Danielle Bolen, MD.

CMS Open Payments shows 4 general payments to Dr. Kobaivanova from 4 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $121.